Evidence map›Paper›PMID 39968077›Full record

ArticleFrontiers in oncology2025

DeepGlioSeg: advanced glioma MRI data segmentation with integrated local-global representation architecture.

Ruipeng Li, Yuehui Liao, Yueqi Huang, Xiaofei Ma, Guohua Zhao, Yanbin Wang, Chen Song

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruipeng Li *Department of Urology, Hangzhou Third People's Hospital, Hangzhou, China.
Yuehui Liao *College of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Yueqi Huang *Department of Psychiatry, Hangzhou Seventh People's Hospital, Hangzhou, China.
Xiaofei MaCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Guohua ZhaoDepartment of Magnetic Resonance Imaging, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yanbin WangDepartment of Urology, Hangzhou Third People's Hospital, Hangzhou, China.
Chen SongDepartment of Urology, Hangzhou Third People's Hospital, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Glioma segmentation is vital for diagnostic decision-making, monitoring disease progression, and surgical planning. However, this task is hindered by substantial heterogeneity within gliomas and imbalanced region distributions, posing challenges to existing segmentation methods. Methods: To address these challenges, we propose the DeepGlioSeg network, a U-shaped architecture with skip connections for continuous contextual feature integration. The model includes two primary components. First, a CTPC (CNN-Transformer Parallel Combination) module leverages parallel branches of CNN and Transformer networks to fuse local and global features of glioma images, enhancing feature representation. Second, the model computes a region-based probability by comparing the number of pixels in tumor and background regions and assigns greater weight to regions with lower probabilities, thereby focusing on the tumor segment. Test-time augmentation (TTA) and volume-constrained (VC) post-processing are subsequently applied to refine the final segmentation outputs. Results: Extensive experiments were conducted on three publicly available glioma MRI datasets and one privately owned clinical dataset. The quantitative and qualitative findings consistently show that DeepGlioSeg achieves superior segmentation performance over other state-of-the-art methods. Discussion: By integrating CNN- and Transformer-based features in parallel and adaptively emphasizing underrepresented tumor regions, DeepGlioSeg effectively addresses the challenges associated with glioma heterogeneity and imbalanced region distributions. The final pipeline, augmented with TTA and VC post-processing, demonstrates robust segmentation capabilities. The source code for this work is publicly available at https://github.com/smallboy-code/Brain-tumor-segmentation.

Indexed as

automated segmentationconvolutional neural networkCTPCgliomamagnetic resonance imaging

Identifiers

PMID39968077
PMCPMC11832817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.